These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30936525)
21. [CRISPR/Cas systems in genome engineering of bacteriophages]. Liang CJ; Meng FM; Ai YC Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946 [TBL] [Abstract][Full Text] [Related]
22. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6. Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602 [TBL] [Abstract][Full Text] [Related]
23. Five big mysteries about CRISPR's origins. Ledford H Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279 [No Abstract] [Full Text] [Related]
24. Genomic impact of CRISPR immunization against bacteriophages. Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225 [TBL] [Abstract][Full Text] [Related]
25. Directed Evolution of CRISPR-Cas9 Base Editors. Winter J; Perez-Pinera P Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959 [TBL] [Abstract][Full Text] [Related]
26. And Then There Were Three: Discovering the Role of CRISPRs. Vergnaud G CRISPR J; 2019 Dec; 2(6):359-361. PubMed ID: 31860354 [No Abstract] [Full Text] [Related]
27. Evolutionary causes and consequences of diversified CRISPR immune profiles in natural populations. England WE; Whitaker RJ Biochem Soc Trans; 2013 Dec; 41(6):1431-6. PubMed ID: 24256233 [TBL] [Abstract][Full Text] [Related]
29. CRISPR off-targets: a question of context. Haeussler M Cell Biol Toxicol; 2020 Feb; 36(1):5-9. PubMed ID: 31734746 [No Abstract] [Full Text] [Related]
30. Regulation of the CRISPR-Associated Genes by Rv2837c (CnpB) via an Orn-Like Activity in Tuberculosis Complex Mycobacteria. Zhang Y; Yang J; Bai G J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378893 [TBL] [Abstract][Full Text] [Related]
31. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells. Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779 [TBL] [Abstract][Full Text] [Related]
32. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems. Giovannangeli C; Concordet JP Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487 [No Abstract] [Full Text] [Related]
34. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems. Hwang S; Maxwell KL CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234 [TBL] [Abstract][Full Text] [Related]
35. Mathematical modelling of CRISPR-Cas system effects on biofilm formation. Ali Q; Wahl LM J Biol Dyn; 2017 Aug; 11(sup2):264-284. PubMed ID: 28426329 [TBL] [Abstract][Full Text] [Related]
36. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology. Hashemi A Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500 [TBL] [Abstract][Full Text] [Related]
37. CRISPR on the Move in 2019. Barrangou R CRISPR J; 2019 Feb; 2():1-2. PubMed ID: 31021232 [No Abstract] [Full Text] [Related]
38. Genome editing: The domestication of Cas9. Urnov F Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037 [No Abstract] [Full Text] [Related]